Crohns & Colitis Congress
Q&A: ‘Everyone benefits’ from noninvasive, individualized monitoring in pediatric IBD
SAN FRANCISCO — Noninvasive monitoring methods, such as enterography and ultrasound, are becoming increasingly recognized as essential tools in the management of pediatric patients with inflammatory bowel disease, according to presenters.
VIVID-2: Omvoh demonstrates ‘continued durability,’ safety in Crohn’s disease at 2 years
SAN FRANCISCO — Most patients with moderately to severely active Crohn’s disease who achieved endoscopic response and remission after 52 weeks of Omvoh therapy maintained those results through 104 weeks, according to VIVID-2 study results.
Train support staff to be aware of mental health concerns in IBD to avoid future trauma
SAN FRANCISCO — Patients with inflammatory bowel disease remain at higher risk for mental health disorders, but training support staff to recognize the symptoms could be key to preventing further traumatization, noted a presenter here.
Most patients with IBD ‘still experience significant challenges’ accessing, affording care
SAN FRANCISCO — Despite advances in treatment for inflammatory bowel disease, more than 55% of patients report medication delays, mostly due to insurance challenges, and many make financial trade-offs to afford care, survey results showed.
‘Lack of patient activation’ in pediatric IBD may be poor health literacy in disguise
SAN FRANCISCO — Patient activation, earned trust and health literacy at patient, provider and health system levels are critical to overcoming health disparities among pediatric patients with inflammatory bowel disease, noted a presenter.